The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
ArticleNo Access

BLOOD PRESSURE RESPONSES OF CHRONIC SCHIZOPHRENIC PATIENTS TO EPINEPHRINE AND MECHOLYL

Published Online:https://doi.org/10.1176/ajp.112.10.808

1. The recent work of Funkenstein, Greenblatt, and Solomon on the Epinephrine-Mecholyl Test, and on autonomic nervous system responses of mentally ill patients, has been applied to chronic schizophrenics.

2. Our hypothesis was that if chronic schizophrenics were tested by this technique, few would give responses of the type that are associated with a favorable prognosis.

3. Of 25 chronic schizophrenics with prolonged hospitalizations, none gave a "favorable" response.

4. The responses shown by chronic patients gave a distribution pattern practically identical with that seen in groups of normal subjects. The distribution into groups of the more acute cases described by Funkenstein et al. differs significantly from both normals and chronics.

5. Hypotheses have been formulated from the work of Funkenstein and from the results of this investigation which pertain to concepts of psychological equilibrium and homeostasis in mental illness.

6. Our results give support to the reliability of the Epinephrine-Mecholyl Test. Further work with this test should be done.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.